| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |